Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Functional Testing to Understand Your System We begin with deep, targeted testing
LR3 is a variant designed to reduce IGF-binding protein affinity , helping more ligand reach the IGF-1 receptor
Gene transfer of a human insulin-like growth factor I cDNA enhances tissue engineering of cartilage
Boehringer Ingelheim says the GLP-1/FGF21 agonist planned by the companies would complement its existing NASH pipeline, which has focused on developing next-generation therapies that target three key drivers of the liver disease: steatosis, inflammation, and fibrosis
Lilly plans to start conducting larger trials with the drug soon
US$ 21.73
US$ 23.89
US$ 28.74
